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Background
Primary vasculitis of the central nervous system is a newly
recognized, devastating inflammatory disease restricted to
the brain and spinal cord. Previously healthy children and
adults develop life-threatening neurological deficits includ-
ing stroke and seizures. Within CNS vasculitis distinct dis-
ease entities have been identified in different age groups.
The aim was to describe the presenting features of chil-
dren and adults with CNS vasculitis, to compare distinct
entities and their treatment regimens between adult and
children and to analyze disease progression and/or relapse.
Methods
Two cohorts of consecutive patients with primary CNS
vasculitis based on Calabrese criteria diagnosed over a 21
year period and followed at tertiary vasculitis centers were
identified: 1) adult patients (Mayo Clinic, Rochester) and
2) pediatric patients (Sickkids, Toronto). Patient demo-
graphic characteristics, presenting clinical features, neuroi-
maging characteristics, brain pathology results, clinical
course including progression and relapse and treatment
regimens were recorded. Characteristics of cohorts were
analyzed using descriptive statistics. Univariate analysis
compared distinct disease phenotypes and treatment regi-
mens. Kaplan Meier survival analysis was performed to
determine survival after CNS vasculitis diagnosis.
Results
A total of 227 patients were included in the study; 101
adult patients and 126 pediatric patients. In children the
median age was 8 years (1-17 years) and in adults 47
years (17-84 years). Pediatric patients showed a male
predominance (F: M = 1:1.5) in contrast with the adult
cohort (F:M = 1.3: 1). Diagnosis was established on
angiography only in 88 pediatric and 52 adult patients,
and on brain biopsy with negative angiography in 29
pediatric and 8 adult patients. Vessels involved were: in
children 35 small vessel and 91 large vessel, in adults 22
small vessel, 6 large vessel and 48 small and large ves-
sels. Brain biopsy: performed in 49% of adult patients
with a male predominance (F: M = 1:1.2) compared to
2 5 %i nc h i l d r e nw i t haf e m a l ep r e d o m i n a n c e( F : M=
1.9:1). Histology showed only lymphocytic inflammation
in children and predominantly a granulomatous pattern
in adults (18 granulomatous, 8 lymphocytic, 5 acute
necrotizing). Treatment strategies: in children predni-
sone in 59 (47%) and cyclophosphamide in 34 (27%), in
adults prednisone in 97 (96%) and cyclophosphamide in
46 patients (46%). Relapse or progression of the disease
was seen in adults in 26% and in children in 15%.
Conclusion
Distinct differences are present in the spectrum of pri-
mary CNS vasculitis in adults and children. Biopsy only
or angiography only confirmed disease shows different
gender predominance in adults compared to children.
Adults are treated more frequently with steroids and
cyclophosphamide, however relapse rates are lower in
children.
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